Rituximab for steroid-refractory chronic graft-versus-host disease - Cutler, Corey; Miklos, David; Kim, Haesook T.; Treister, Nathaniel; Woo, Sook-Bin; Bienfang, Don; Klickstein, Lloyd B.; Levin, Jesse; Miller, Katherine; Reynolds, Carol; Macdonell, Rebecca; Pasek, Mildred; et al. (Blood, 2006)
Keywords: Adult; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy; Antibodies, Monoclonal - administration & dosage; Antibodies, Monoclonal, Murine-Derived; B-Lymphocytes - drug effects; B-Lymphocytes - pathology; Biological and medical sciences; Bone marrow, stem cells transplantation. Graft versus host reaction; Chronic Disease; Drug Resistance; Female; Graft vs Host Disease - drug therapy; Graft vs Host Disease - pathology; Humans; Male; Medical sciences; Middle Aged; Musculoskeletal Diseases - drug therapy; Musculoskeletal Diseases - etiology; Prednisone - pharmacology; Rituximab; Salvage Therapy - methods; Skin Diseases - drug therapy; Skin Diseases - etiology; Steroids - pharmacology; Transfusions. Complications. Transfusion reactions. Cell and gene therapy; Transplantation; Human; Steroid; Immunopathology; Treatment resistance; Chronic disease; Stem cell; Hematopoietic cell; Homograft; Rituximab; Graft versus host reaction; Monoclonal antibody; Treatment; Immunotherapy; Anticytokine; Graft